GB2038669A - Enhancement of separation of cell layers in centrifuged blood samples - Google Patents

Enhancement of separation of cell layers in centrifuged blood samples Download PDF

Info

Publication number
GB2038669A
GB2038669A GB7900763A GB7900763A GB2038669A GB 2038669 A GB2038669 A GB 2038669A GB 7900763 A GB7900763 A GB 7900763A GB 7900763 A GB7900763 A GB 7900763A GB 2038669 A GB2038669 A GB 2038669A
Authority
GB
United Kingdom
Prior art keywords
cells
red
blood
sample
additive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB7900763A
Other versions
GB2038669B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB7900763A priority Critical patent/GB2038669B/en
Publication of GB2038669A publication Critical patent/GB2038669A/en
Application granted granted Critical
Publication of GB2038669B publication Critical patent/GB2038669B/en
Expired legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5021Test tubes specially adapted for centrifugation purposes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D43/00Separating particles from liquids, or liquids from solids, otherwise than by sedimentation or filtration

Abstract

An improvement in the degree of separation of constituent cell layers in a centrifuged sample of human blood can be achieved by decreasing the natural water content of the red blood cells to increase their specific gravity. Thus, during centrifugation, the red cell layer packs more tightly and separates more completely from the next lighter cell layer adjacent thereto, i.e. the granulocyte layer. This is achieved by adding to the blood sample, before centrifuging, an amount of a suitable additive such as potassium oxalate, lithium lactate or sodium citrate. The additive apparently causes intracellular water to be removed from the red cells by osmosis.

Description

SPECIFICATION Enhancement of separation of cell layers in centrifuged blood samples The invention relates to techniques for making approximate white cell blood counts and granulocyte/mononuclear ratio cell counts, and particularly to a technique for enhancement of the separation of individual layers in a centrifuged blood sample. The invention is related to and useful in conjunction with the techniques of blood testing disclosed in the specification of British Patent Application No. 11138/ 77 Serial No 1544337.
The techniques disclosed in the referenced specification relate to the measurement of approximate white cell blood counts, platelet counts, and granulocyte/mononuclear ratio counts and to methods and paraphenalia used in such measurements. Generally the techniques involve the centrifugation of a blood sample in a tube which contains a volumeoccupying insert which floats upon the red cell layer and axially elongates the buffy coat or white cell and platelet layer by a multiple of four or more. The blood sample being tested in anticoagulated blood.
The order of layering by density or specific gravity of an anticoagulated human blood sample in this technique from lightest constituent to heaviest constituent is plasma, followed by platelets, followed by mononuclear cells, followed by granulocytes and finally red cells. In the type of system described in the referenced specification, separation of each layer is usually adequate for visual identification and gives relatively sharp interface delineation with the exception of the interface between the granulocyte layer and the red cell layer, which is often hazy and ill-defined in appearance.
The reason for this is that, in some blood samples, the difference between the density of specific gravity of the individual granulocyte cells and the youngest and lightest red cells is not great enough to provide a sharp demarcation line between these adjacent cell layers. This lack of a sharp demarcation line is the direct result of the lighter young red cells tending to intermingle with the granulocyte cells nearthe common interface and causes difficulties in accurately measuring the extent of the red cell layer and the granulocyte layer.
According to the invention, there is provided a method of clarifying the interface between an axially elongated granulocyte cell layer and a red cell layer in a centrifuged sample of blood comprising adding to the blood sample before centrifuging an additive in an amount effective to prevent any immature red cells from being suspended in an adjacent layer of granulocyte cells by increasing the specific gravity of the red cells without significantly altering the specific gravit- of a significant number of the granulocyte cells.
The various cellular components of blood can be thought of as "sacks" of protein, each surrounded by membranes which are freely permeable to water and selectively permeable to other substances. Since the density or specific gravity of the blood cells depends primarily on the ratio of intracellular water to protein, changing this ratio will change the density or specific gravity of the cells.
By adding a substance to the blood sample which effectively increases the density of the red cells without significantly effecting the density of the granulocytes the younger red cells can be caused to pack tightly into the remaining red cell mass and the demarcation line between the granulocyte layer and the red cell layer in a sample of centrifuged anticoagulated blood can be sharpened or better defined. The particular substance added to the blood sample is a substance which extracts water from the red cells, thus rendering them more dense, but does not significantly affect the intracellular water-toprotein ratio of the granulocytes or other cell types and thus does not significantly change their natural density.
We theorize that the mechanism by which the substance operates is as follows. The membranes surrounding individual red cells are, in general, less permeable to substances than are the membranes surrounding the other individual cell types in blood.
Thus, a substance is added to the blood sample which freely moves through each of the cell type membranes except the red cell membrane. The addition of such a substance causes intracellular water to be removed from the red cells by the process of osmosis. This removal of intracellular water from the red cells increases their density or specific gravity. At the same time, since the added substance moves freely through the remainder of the blood cell membranes, substantially no intracellular water is removed therefrom, thus their density or specific gravity is not increased. The overall result is that the "densified" red cells, including the young red cells, pack more tightly, but the remaining cells, including the granulocytes, pack in substantially the same manner as they do without the addition of the substance.Thus, the young red cells pack tightly into the red cell mass and no longer obscure the demarcation line between the red cells and the granulocytes.
The substance which we prefer to use for selectively altering the specific gravity of the red blood cell constituent in the manner specified above is potassium oxalate. One reason for preferring potassium oxalate is that, in addition to its excellent ability desirably to alter the specific gravity of the red blood cell types, it is also an anticoagulant for the blood.
Thus, it performs a dual function. When potassium oxalate is used merely for its anticoagulant function, it is used in a concentration of about 200 mg/dl of solution. This concentration will cause about an 8% shrinkage of the red cells due to a loss of intracellular water whereby the density or specific gravity of the red cells is increased. This "merely anticoagulating" concentration of 200 mg/dl is not sufficient to provide the degree of separation of red cells from white cells which we require, however. We prefer to use a potassium oxalate concentration in the range of about 400 mgldl to about 600 mgldl solution to provide the required degree of cell separation. This increased concentration does not adversely affect the ability of the potassium oxalate to anticoagulate the blood sample.Furthermore, this increased con centration of potassium oxalate does not significantly increase the density of a significant portion of the white cells in a majority of blood samples, whereby good separation can be achieved without the need to make any mathematical corrections for the white cell layer thicknesses observed. The increased density of the red cells due to the addition of greater than conventional concentrations of potassium oxalate results in a more compact red cell mass than usually observed; however, the hematocrit reading for the blood sample can still be made by mathematically correcting the observed red cell column height.It should be noted that the red cell densification result of adding even a conventional 200 mgldl solution of potassium oxalate to a blood sample for anticoagulating purposes has, in the past, resulted in that particular anticoagulant not being used in blood tests which include a hematocrit count. Instead, other non-densifying anticoagulants, such as heparin, have been used.
Other reagents which will provide an improved separation line between the red cells and the granulocytes are lithium lactate and sodium citrate.
Of the three reagents, potassium oxalate is most preferred, lithium lactate is next preferred, and sodium citrate is least preferred. Compounds noted which are operable selectively to render the red cells more dense while not affecting the white cells are compounds which have an organic anion in combination with a freely soluble metallic cation.
A specific example of the use of potassium oxalate mixture which is preferred is as follows. Blood from a donor was divided into 0.5 ml. aliquots. To one of the aliquots was added sufficient potassium oxalate to raise the whole blood osmolality by 50 milliosmoles/litre. In making this calculation, all cells were considered as producing an osmotic effect, and complete disassociation was assumed. The blood was then drawn into capillary tubes and spun down.
A control sample with no additives showed fair separation between the red cell and granulocyte layers. The sample containing the potassium oxalate showed excellent separation between the red cell and granulocyte layers.
The additive is preferably deposited in a dry form on the inside surface of the capillary tube in which the testing procedure is carried out by means of freeze drying. Other coating procedures can be used, however.
The invention is diagrammatically illustrated by way of example in the accompanying drawing which shows a sectional view of a capillary testing tube assembly for use in carrying out the invention.
Referring to the drawing, a capillary tube 2 has a plastics volume-occupying insert 4 in the form of a right cylinder with an upper, inwardly tapered end portion. The insert 4 can be prevented from falling out of the tube bore by crimping the ends of the tube inwardly, as at 6. Alternatively, a blood-soluble adhesive can be used to hold the insert 4 in place.
Gum acacia is such an adhesive. Substantiallythe entire length L of the tube bore wall 8 is preferably coated with a dry layer of the additive which increases the density of the red cells but does not significantly increase the density of the white cells. The tube assembly shown is used by drawing the blood sample into it. The blood flowing into the tube dissolves the dry coating of the additive and causes it to go into solution in the blood. It is then free to perform its intended function.
It will be appreciated that the method of this invention can be performed by adding the reagent, preferably potassium oxalate, to the blood sample before the sample is drawn into the capillary tube.

Claims (7)

1. A method of clarifying the interface between an axially elongated granulocyte cell layer and a red cell layer in a centrifuged sample of blood comprising adding to the blood sample before centrifuging an additive in an amount effective to prevent any immature red cells from being suspended in an adjacent layer of granulocyte cells by increasing the specific gravity of the red cells without significantly altering the specific gravity of a significant number of the granulocyte cells.
2. A method according to claim 1, wherein the additive is one which effects removal of water from the individual red cells of the sample without significantly effecting removal of water from white cells thereof.
3. A method according to claim 1 or claim 2, wherein the additive is potassium oxalate.
4. A method according to claim 3, wherein the potassium oxalate is added at a concentration of 400 to 600 mg/dl of solution.
5. A method according to any one of claims 1 to 4, wherein the blood sample is drawn into a capillary tube which already includes said additive; and the sample in the capillary tube is centrifuged to separate the sample into a layer of red cells and an adjacent layer of white cells.
6. A method according to claim 1, wherein the additive is a compound having an organic anion in combination with a freely soluble metallic cation in an amount effective to increase the specific gravity of the red cells thereby preventing any immature red cells from being suspended in an adjacent layer of buffy coat cells without significantly altering the specific gravity of a significant number of the buffy coat cells.
7. A method for clarifying the interface between an axially elongated granulocyte cell layer and the red cell layer in a centrifuged sample of blood as claimed in claim 1 and substantially as hereinbefore described.
GB7900763A 1979-01-09 1979-01-09 Enhancement of separation of cell layers in centrifuged blood samples Expired GB2038669B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB7900763A GB2038669B (en) 1979-01-09 1979-01-09 Enhancement of separation of cell layers in centrifuged blood samples

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7900763A GB2038669B (en) 1979-01-09 1979-01-09 Enhancement of separation of cell layers in centrifuged blood samples

Publications (2)

Publication Number Publication Date
GB2038669A true GB2038669A (en) 1980-07-30
GB2038669B GB2038669B (en) 1982-08-18

Family

ID=10502405

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7900763A Expired GB2038669B (en) 1979-01-09 1979-01-09 Enhancement of separation of cell layers in centrifuged blood samples

Country Status (1)

Country Link
GB (1) GB2038669B (en)

Also Published As

Publication number Publication date
GB2038669B (en) 1982-08-18

Similar Documents

Publication Publication Date Title
US4159896A (en) Enhancement of separation of cell layers in centrifuged blood sample
CA1306680C (en) Method for separating the cellular components of blood samples
US5432054A (en) Method for separating rare cells from a population of cells
US5707876A (en) Method and apparatus for harvesting constituent layers from a centrifuged material mixture
CA1210693A (en) Method and apparatus for separating lymphocytes from anticoagulated blood
CA2182367C (en) Density gradient medium for separating cells
US4867887A (en) Method and apparatus for separating mononuclear cells from blood
US4957638A (en) Method for separating the cellular components of blood samples
EP0385953B1 (en) Apparatus for separating mononuclear cells from blood and method of manufacturing and using the same
EP0392377B1 (en) Method and device for the separation of plasma or serum from whole blood
US5552064A (en) Column agglutination assay and device using biphasic centrifugation
US3492396A (en) Agglutinate separation method and apparatus
CA2365925C (en) Method of separating cells from a sample
EP0200303A1 (en) Measurement of a small most dense constituent layer in a stratified mixture
US5550060A (en) Method and procedure for preparing red blood fractions
Tillmann et al. Rheological properties of young and aged human erythrocytes
EP0225703A2 (en) Method of improving the demarcation and separation of cells in centrifuged blood samples
EP0553554B1 (en) Method and means for density gradient centrifugation
US4181609A (en) Blood constituents testing method
Kenny et al. Methods for removal of leucocytes and platelets prior to study of erythrocyte deformability
EP0844482A2 (en) Process for enhancing the aggregation and/or agglutination of erythrocytes prior to centrifugation
GB2038669A (en) Enhancement of separation of cell layers in centrifuged blood samples
US4224942A (en) Cell fractionating method
Snyder et al. Hematology, viscosity, and respiratory functions of whole blood of the lesser mouse deer, Tragulus javanicus
SU1439500A1 (en) Method of quantitative analysis of reticulocytes in blood

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930109